Skip to main content
. 2018 Apr;76(4):383–392. doi: 10.1016/j.jinf.2017.12.006

Table 3.

Admission clinical features.

Clinical Features Total (n = 44)a Survived (n = 21) Died (n = 20) p-value
 Anorexia 29/44 13/21 15/20 0.342
 Abdominal pain 28/44 13/21 15/20 0.132
 Back pain 9/44 5/21 4/20 1.0
 Conjunctival injection 10/44 5/21 5/20 1.0
 Diarrhoea & vomiting 33/44 13/21 19/20 0.006
 Dyspnoea 7/44 2/21 5/20 0.217
 Delirium/encephalopathy 11/44 2/21 9/20 0.012
 Fever 27/44 14/21 11/20 0.539
 Haemorrhage 3/44 2/21 1/20 0.583
 Headache 25/44 13/21 10/20 0.543
 Hiccups 10/44 2/21 8/20 0.027
 Lethargy/malaise 31/44 12/21 17/20 0.096
 Myalgia 25/44 11/21 12/20 0.766
 Arthralgia 19/44 10/21 7/20 0.372
 Nausea 23/44 9/21 13/20 0.143
Vital signs at admission
 Pulse – mean (SD) 90.6 (16.9) 89.2 (19) 92 (16) 0.58
 Systolic BP – mean (SD) 125 (21.3) 118 (19) 134 (21) 0.02
 Temperature – median (range) 37.3 (36.1–39.6) 37.2 (36.1–39.6) 37.4 (36.3–39.2) 0.354
 Respiratory rate – median (range) 22 (14–44) 23 (17–44) 22 (14–42) 0.217
 Saturations – median (range) 97 (83–99) 96 (83–99) 98 (91–99) 0.02
EVD stage at admission
 Stage 1 9/44 6/21 1/20
 Stage 2 12/44 8/21 3/20
 Stage 3 23/44 7/21 16/20 0.009
Highest EVD stage during admission
 Stage 1 1/41 1/21 0/20
 Stage 2 8/41 8/21 0/20 0.004
 Stage 3 32/41 12/21 20/20
NEWS score at admission
Mean (SD)
4.1 (3.5) 3 (1.9) 5.5 (4.4) 0.02
qSOFA score at admission
Median (range)
1 (0–3) 1 (0–2) 1 (0–3) 0.359
Ct value at admission (n = 42)
Median
20.7 (14.3–37.2) 23.4 (16.2–37.2) 19.6 (14.3–32.1) 0.001
a

44 patients with confirmed EVD were managed at the EVD treatment unit, with 41 admitted until discharge/death. 3 patients were aeromedically evacuated to the USA/Europe. (SD – standard deviation, BP – blood pressure, qSOFA – quick Sepsis Related Organ Failure Assessment, Ct – cycle threshold).